 | • レポートコード：MRC2312MG03177 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のロミプロスチム注射市場規模と予測を収録しています。・世界のロミプロスチム注射市場：売上、2018年-2023年、2024年-2029年 ・世界のロミプロスチム注射市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のロミプロスチム注射市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「250 μg/0.5 mL」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ロミプロスチム注射のグローバル主要企業は、Amgen、 Kyowa Kirin、 Intas Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ロミプロスチム注射のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のロミプロスチム注射市場：タイプ別、2018年-2023年、2024年-2029年 世界のロミプロスチム注射市場：タイプ別市場シェア、2022年 ・250 μg/0.5 mL、500 μg/1 mL 世界のロミプロスチム注射市場：用途別、2018年-2023年、2024年-2029年 世界のロミプロスチム注射市場：用途別市場シェア、2022年 ・成人、小児 世界のロミプロスチム注射市場：地域・国別、2018年-2023年、2024年-2029年 世界のロミプロスチム注射市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるロミプロスチム注射のグローバル売上、2018年-2023年 ・主要企業におけるロミプロスチム注射のグローバル売上シェア、2022年 ・主要企業におけるロミプロスチム注射のグローバル販売量、2018年-2023年 ・主要企業におけるロミプロスチム注射のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Amgen、 Kyowa Kirin、 Intas Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 ロミプロスチム注射市場の定義 市場セグメント 世界のロミプロスチム注射市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のロミプロスチム注射市場規模 世界のロミプロスチム注射市場規模：2022年 VS 2029年 世界のロミプロスチム注射市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのロミプロスチム注射の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のロミプロスチム注射製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：250 μg/0.5 mL、500 μg/1 mL ロミプロスチム注射のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：成人、小児 ロミプロスチム注射の用途別グローバル売上・予測 ・地域別市場分析 地域別ロミプロスチム注射市場規模 2022年と2029年 地域別ロミプロスチム注射売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Amgen、 Kyowa Kirin、 Intas Pharmaceuticals ... |
This research report provides a comprehensive analysis of the Romiplostim Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Romiplostim Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Romiplostim Injection, challenges faced by the industry, and potential opportunities for market players.
The global Romiplostim Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Romiplostim Injection market presents opportunities for various stakeholders, including Adults, Pediatric Patients. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Romiplostim Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Romiplostim Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Romiplostim Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Romiplostim Injection market.
Market Overview: The report provides a comprehensive overview of the Romiplostim Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 250 μg/0.5 mL, 500 μg/1 mL), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Romiplostim Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Romiplostim Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Romiplostim Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Romiplostim Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Romiplostim Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Romiplostim Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Romiplostim Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Romiplostim Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Romiplostim Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
250 μg/0.5 mL
500 μg/1 mL
Market segment by Application
Adults
Pediatric Patients
Global Romiplostim Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Amgen
Kyowa Kirin
Intas Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Romiplostim Injection, market overview.
Chapter 2: Global Romiplostim Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Romiplostim Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Romiplostim Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Romiplostim Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Romiplostim Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Romiplostim Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Romiplostim Injection Overall Market Size
2.1 Global Romiplostim Injection Market Size: 2022 VS 2029
2.2 Global Romiplostim Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Romiplostim Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Romiplostim Injection Players in Global Market
3.2 Top Global Romiplostim Injection Companies Ranked by Revenue
3.3 Global Romiplostim Injection Revenue by Companies
3.4 Global Romiplostim Injection Sales by Companies
3.5 Global Romiplostim Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Romiplostim Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Romiplostim Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Romiplostim Injection Players in Global Market
3.8.1 List of Global Tier 1 Romiplostim Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Romiplostim Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Romiplostim Injection Market Size Markets, 2022 & 2029
4.1.2 250 μg/0.5 mL
4.1.3 500 μg/1 mL
4.2 By Type – Global Romiplostim Injection Revenue & Forecasts
4.2.1 By Type – Global Romiplostim Injection Revenue, 2018-2023
4.2.2 By Type – Global Romiplostim Injection Revenue, 2024-2029
4.2.3 By Type – Global Romiplostim Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Romiplostim Injection Sales & Forecasts
4.3.1 By Type – Global Romiplostim Injection Sales, 2018-2023
4.3.2 By Type – Global Romiplostim Injection Sales, 2024-2029
4.3.3 By Type – Global Romiplostim Injection Sales Market Share, 2018-2029
4.4 By Type – Global Romiplostim Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Romiplostim Injection Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Pediatric Patients
5.2 By Application – Global Romiplostim Injection Revenue & Forecasts
5.2.1 By Application – Global Romiplostim Injection Revenue, 2018-2023
5.2.2 By Application – Global Romiplostim Injection Revenue, 2024-2029
5.2.3 By Application – Global Romiplostim Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Romiplostim Injection Sales & Forecasts
5.3.1 By Application – Global Romiplostim Injection Sales, 2018-2023
5.3.2 By Application – Global Romiplostim Injection Sales, 2024-2029
5.3.3 By Application – Global Romiplostim Injection Sales Market Share, 2018-2029
5.4 By Application – Global Romiplostim Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Romiplostim Injection Market Size, 2022 & 2029
6.2 By Region – Global Romiplostim Injection Revenue & Forecasts
6.2.1 By Region – Global Romiplostim Injection Revenue, 2018-2023
6.2.2 By Region – Global Romiplostim Injection Revenue, 2024-2029
6.2.3 By Region – Global Romiplostim Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Romiplostim Injection Sales & Forecasts
6.3.1 By Region – Global Romiplostim Injection Sales, 2018-2023
6.3.2 By Region – Global Romiplostim Injection Sales, 2024-2029
6.3.3 By Region – Global Romiplostim Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Romiplostim Injection Revenue, 2018-2029
6.4.2 By Country – North America Romiplostim Injection Sales, 2018-2029
6.4.3 US Romiplostim Injection Market Size, 2018-2029
6.4.4 Canada Romiplostim Injection Market Size, 2018-2029
6.4.5 Mexico Romiplostim Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Romiplostim Injection Revenue, 2018-2029
6.5.2 By Country – Europe Romiplostim Injection Sales, 2018-2029
6.5.3 Germany Romiplostim Injection Market Size, 2018-2029
6.5.4 France Romiplostim Injection Market Size, 2018-2029
6.5.5 U.K. Romiplostim Injection Market Size, 2018-2029
6.5.6 Italy Romiplostim Injection Market Size, 2018-2029
6.5.7 Russia Romiplostim Injection Market Size, 2018-2029
6.5.8 Nordic Countries Romiplostim Injection Market Size, 2018-2029
6.5.9 Benelux Romiplostim Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Romiplostim Injection Revenue, 2018-2029
6.6.2 By Region – Asia Romiplostim Injection Sales, 2018-2029
6.6.3 China Romiplostim Injection Market Size, 2018-2029
6.6.4 Japan Romiplostim Injection Market Size, 2018-2029
6.6.5 South Korea Romiplostim Injection Market Size, 2018-2029
6.6.6 Southeast Asia Romiplostim Injection Market Size, 2018-2029
6.6.7 India Romiplostim Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Romiplostim Injection Revenue, 2018-2029
6.7.2 By Country – South America Romiplostim Injection Sales, 2018-2029
6.7.3 Brazil Romiplostim Injection Market Size, 2018-2029
6.7.4 Argentina Romiplostim Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Romiplostim Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Romiplostim Injection Sales, 2018-2029
6.8.3 Turkey Romiplostim Injection Market Size, 2018-2029
6.8.4 Israel Romiplostim Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Romiplostim Injection Market Size, 2018-2029
6.8.6 UAE Romiplostim Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Romiplostim Injection Major Product Offerings
7.1.4 Amgen Romiplostim Injection Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Kyowa Kirin
7.2.1 Kyowa Kirin Company Summary
7.2.2 Kyowa Kirin Business Overview
7.2.3 Kyowa Kirin Romiplostim Injection Major Product Offerings
7.2.4 Kyowa Kirin Romiplostim Injection Sales and Revenue in Global (2018-2023)
7.2.5 Kyowa Kirin Key News & Latest Developments
7.3 Intas Pharmaceuticals
7.3.1 Intas Pharmaceuticals Company Summary
7.3.2 Intas Pharmaceuticals Business Overview
7.3.3 Intas Pharmaceuticals Romiplostim Injection Major Product Offerings
7.3.4 Intas Pharmaceuticals Romiplostim Injection Sales and Revenue in Global (2018-2023)
7.3.5 Intas Pharmaceuticals Key News & Latest Developments
8 Global Romiplostim Injection Production Capacity, Analysis
8.1 Global Romiplostim Injection Production Capacity, 2018-2029
8.2 Romiplostim Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Romiplostim Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Romiplostim Injection Supply Chain Analysis
10.1 Romiplostim Injection Industry Value Chain
10.2 Romiplostim Injection Upstream Market
10.3 Romiplostim Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Romiplostim Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer